Savara Inc. (SVRA)
PHARMACEUTICAL PREPARATIONS
Savara Inc. (SVRA) is listed on Nasdaq, where it has traded since November 18, 1996.
- Listed On
- Nasdaq
- Listed Since
- November 18, 1996
- Employees
- 70
- Market Cap
- $1.0B
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 175 institutions reported holding SVRA, with 217.0 million shares worth $1.3 billion in aggregate. The largest reported holder was Nea Management Company, with 24.5 million shares worth $150.7 million. Of the 5 largest holders listed below, 2 added shares and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Nea Management Company | 24,471,264 | $151M | Unchanged |
| Bain Capital Life Sciences Investors | 17,600,621 | $108M | Unchanged |
| VR Adviser | 14,745,943 | $91M | Added 7.32% |
| Deerfield Management Company | 13,569,000 | $84M | Unchanged |
| BlackRock | 12,494,498 | $77M | Added 10.66% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is SVRA?
Savara Inc. (SVRA) is listed on Nasdaq, where it has traded since November 18, 1996.
Who are the largest institutional holders of SVRA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of SVRA were Nea Management Company, Bain Capital Life Sciences Investors and VR Adviser.
How many institutions own SVRA?
175 institutions reported a position in SVRA for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell SVRA last quarter?
Of the 5 largest reported holders, 2 added shares and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for SVRA.
Every reported institutional holder, plus insider and congressional trades in SVRA, on SentiSense.